Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 12 August 2024 — This...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 9 August 2024 — This...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 8 August 2024 — This...
Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 06 August 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase...
Novo Nordisk A/S – Share repurchase programme Bagsværd, Denmark, 29 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme...
European regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 22 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 15 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme...
Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec Bagsværd, Denmark, 10 July 2024 – Novo Nordisk today...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 08 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 01 July 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase...
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss Bagsværd, Denmark, 26 June 2024 – Novo Nordisk today...
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline In 2024, Novo Nordisk plans to boost its current...
Novo Nordisk A/S - share repurchase programme Bagsværd, Denmark, 24 June 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.